KALEIDEX GROUP LIMITED

Active London

Manufacture of medical and dental instruments and supplies

3 employees website.com
Manufacture of medical and dental instruments and suppliesActivities of production holding companies
K

KALEIDEX GROUP LIMITED

Manufacture of medical and dental instruments and supplies

Founded 26 May 2024 Active London, England 3 employees website.com
Manufacture of medical and dental instruments and suppliesActivities of production holding companies

Previous Company Names

MEDICAL PRECISION GROUP LIMITED 26 May 2024 — 5 Aug 2025
Accounts Submitted 25 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 28 May 2026 Next due 8 Jun 2027 12 months remaining
Net assets £3M
Total assets £3M
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

85 Great Portland Street, First Floor London W1W 7LT England

Website

www.example.com

Full company profile for KALEIDEX GROUP LIMITED (15743517), an active company based in London, England. Incorporated 26 May 2024. Manufacture of medical and dental instruments and supplies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2024–2024)

Cash in Bank

£211.19k

Net Assets

£2.77M

Total Liabilities

N/A

Turnover

N/A

Employees

3

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 41,827,672 Shares £1.42m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
19 Dec 202548,836£49k£1
19 Dec 202548,836£49k£1
21 Sept 2025210,000£21£0
21 Sept 2025210,000£21£0
16 May 2025300,000£300k£1

Officers

Officers

1 active 2 resigned
Status
Marson, Peter NicholasDirectorEnglishUnited Kingdom5526 May 2024Active

Shareholders

Shareholders (7)

Ansor Fund Ii Gp Llp (in Its Capacity As General Partner Of Ansor Fund Ii Lp)
96.8%
40,000,000
Adam Thornton
1.7%
703,750

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Notified 26 May 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

ANSOR LLP united kingdom
ANSOR FUND II GP LLP united kingdom
KALEIDEX GROUP LIMITED Current Company
KALEIDEX LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
28 May 2026Confirmation StatementConfirmation statement made on 25 May 2026 with updates
27 May 2026OfficersAppointment of Mr Jonathan Lynch as director on 22 May 2026
27 May 2026OfficersTermination of Jonathan Lynch as director on 22 May 2026
20 Jan 2026CapitalAllotment of shares (GBP 4,162.7672) on 19 Dec 2025
20 Jan 2026CapitalAllotment of shares (GBP 4,162.7672) on 19 Dec 2025
28 May 2026 Confirmation Statement

Confirmation statement made on 25 May 2026 with updates

27 May 2026 Officers

Appointment of Mr Jonathan Lynch as director on 22 May 2026

27 May 2026 Officers

Termination of Jonathan Lynch as director on 22 May 2026

20 Jan 2026 Capital

Allotment of shares (GBP 4,162.7672) on 19 Dec 2025

20 Jan 2026 Capital

Allotment of shares (GBP 4,162.7672) on 19 Dec 2025

Recent Activity

Latest Activity

Confirmation statement made on 25 May 2026 with updates

1 weeks ago on 28 May 2026

Appointment of Mr Jonathan Lynch as director on 22 May 2026

1 weeks ago on 27 May 2026

Termination of Jonathan Lynch as director on 22 May 2026

1 weeks ago on 27 May 2026

Allotment of shares (GBP 4,162.7672) on 19 Dec 2025

4 months ago on 20 Jan 2026

Allotment of shares (GBP 4,162.7672) on 19 Dec 2025

4 months ago on 20 Jan 2026